- News & Features
The introduction of biologic disease-modifying anti-rheumatic drugs are associated with a decrease in total knee replacements among RA patients.
New research shows that rheumatoid arthritis patients benefit from participating in personalized, digital health coaching.
Rheumatoid arthritis patients who take opioids or antidepressants are likelier to fracture their bones, according to research presented at the 2017 American College of Rheumatology annual meeting in San Diego.
Three presentations at the American College of Rheumatology annual conference in San Diego addressed new classification criteria for systemic lupus...
Treat-to-target, evidence-based guidelines recommend that rheumatoid arthritis patients be monitored regularly for disease activity and that therapy is adjusted —...
Arthritis patients with resolved hepatitis B infection, who received disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, were unlikely to have the hepatitis B resurface.
The question when the first biologic doesn’t work is: What next?
The CreakyJoints Patient Charter can help you be proactive and get the most out of your doctor appointments.
When pain, new symptoms, anxiety and more, coupled with your existing diseases cause you to reach out beyond yourself for help.
A CJ blogger feels lucky about catching her rheumatoid arthritis early but starts to fear what RA progression is doing to her body.